Angiopoietin-like protein 3 inhibitors and contemporary unmet needs in lipid management
Curr Opin Lipidol
.
2021 Jun 1;32(3):210-212.
doi: 10.1097/MOL.0000000000000747.
Authors
Qidi Ying
1
,
Dick C Chan
1
,
Gerald F Watts
1
2
Affiliations
1
School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia.
2
Lipid Disorders Clinic, Department of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.
PMID:
33900278
DOI:
10.1097/MOL.0000000000000747
No abstract available
Publication types
Editorial
MeSH terms
Angiopoietin-Like Protein 3* / antagonists & inhibitors
Humans
Lipid Metabolism* / drug effects
Substances
Angiopoietin-Like Protein 3
Associated data
ClinicalTrials.gov/NCT03747224